Britannia Life Sciences Inc. (BLSIF)

OTCMKTS · Delayed Price · Currency is USD
0.0606
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Market Cap11.94M +33.0%
Revenue (ttm)187.08K -28.5%
Net Income5.90M
EPS0.04
Shares Outn/a
PE Ratio2.02
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume6,508
Open0.0606
Previous Close0.0606
Day's Range0.0606 - 0.0606
52-Week Range0.0400 - 0.0780
Beta-0.12
RSIn/a
Earnings DateFeb 27, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Peter Shippen
Employees 28
Stock Exchange OTCMKTS
Ticker Symbol BLSIF
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements